Yes, and it is one of the most valuable times to do so. The first 1,000 days of life are a "window of opportunity" where the human immune and metabolic system is configured. Monitoring this process is key to the future health of the child.
However, certain scientific limitations must be taken into account:
- Diversity in development: A baby's microbiome is much simpler and less diverse than that of an adult. It is in full transition, especially during breastfeeding and the introduction of complementary feeding.
- Specific reports: Some of our advanced reports (such as the Estrobolome or certain risks of adult chronic pathologies) are not generated for young children, as they would have no clinical validity or practical utility in an organism that has not yet reached microbial maturity.
- Preventive value: Despite this, the test is fundamental to detect early deficits of key bacteria and guide child nutrition to build a resilient microbiota from the base.